Dose selection in seamless phase II/III clinical trials based on efficacy and safety
Peter K. Kimani, Nigel Stallard, Jane L. HuttonVolume:
28
Year:
2009
Language:
english
Pages:
20
DOI:
10.1002/sim.3522
File:
PDF, 234 KB
english, 2009